Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene

Gene Therapy

Volumn 9, Issue 21, 2002, Pages 1472-1479

  Puig, T ^a   Kadar E ^a   Limon A ^b   Cancelas, J A ^c   Eixarch, H ^b   Luquin L ^b   Garcia M ^b   Barquinero, J ^b  

^a UNIVERSITY OF GIRONA   (Spain)

^b BANC DE SANG I TEIXITS   (Spain)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Engraftment; Hematopoietic stem cells; Myeloablation; Retroviral vectors; Tolerance

Indexed keywords

FLUOROURACIL; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; CELL SURVIVAL; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE TRANSFER; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; WHOLE BODY RADIATION;

ANIMALS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LUMINESCENT PROTEINS; MICE; MICE, INBRED C57BL; REGRESSION ANALYSIS; RETROVIRIDAE; STEM CELLS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSPLANTATION CONDITIONING;

ANIMALIA; MURINAE;

EID: 0036847556     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301826     Document Type: Article

References (51)

1. Kiem HP et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 1998; 92: 1878-1886.
2. Schilz AJ et al. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood 1998; 92: 3163-3171.
3. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 1998; 91: 3487-3493.
4. van Hennik PB et al. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood 1998; 92: 4013-4022.
5. Barquinero J et al. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. Blood 2000; 95: 3085-3093.
6. Van Beusechem VW, Valerio D. Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther 1996; 7: 1649-1668.
7. Simonaro CM et al. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation. Gene Therapy 1999; 6: 107-113.
8. Slavin S, Strober S, Fuks Z, Kaplan HS. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science 1976; 193: 1252-1254.
9. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 146: 34-48.
10. Durham MM et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000; 165: 1-4.
11. Naparstek E et al. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. Exp Hematol 1999; 27: 1210-1218.
12. Wekerle T et al. Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade. Transplant Proc 1999; 31: 680.
13. Quesenberry PJ et al. Engraftment of hematopoietic stem cells in nonmyeloablated and myeloablated hosts. Stem Cells 1997; 15 (Suppl 1): 167-169.
14. Rao SS et al. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp Hematol 1997; 25: 114-121.
15. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168-170.
16. Exner BG et al. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts. Acta Haematol 1999; 101: 78-81.
17. Exner BG et al. Clinical applications of mixed chimerism. Ann NY Acad Sci 1999; 872: 377-385.
18. Heim DA et al. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol Ther 2000; 1: 533-544.
19. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11 and SCF acquire an engraftment defect in normal hosts (published erratum appears in Exp Hematol 1995; 23: 568). Exp Hematol 1995; 23: 461-469.
20. Kittler EL et al. Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood 1997; 90: 865-872.
21. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6 IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996; 87: 30-37.
22. Sekhar M, Yu JM, Soma T, Dunbar CE. Murine long-term repopulating ability is compromised by ex vivo culture in serum-free medium despite preservation of committed progenitors. J Hematother 1997; 6: 543-549.
23. Miller CL, Eaves CJ. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci USA 1997; 94: 13648-13653.
24. Albella B et al. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11. Transplantation 1999; 67: 1348-1357.
25. Wognum AW et al. Stimulation of mouse bone marrow cells with kit ligand, FLT3 ligand, and thrombopoietin leads to efficient retrovirus-mediated gene transfer to stem cells, whereas interleukin 3 and interleukin 11 reduce transduction of short- and long-term repopulating cells. Hum Gene Ther 2000; 11: 2129-2141.
26. Stewart FM et al. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993; 81: 2566-2571.
27. Blomberg M et al. Repetitive bone marrow transplantation in nonmyeloablated recipients. Exp Hematol 1998; 26: 320-324.
28. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.
29. McSweeney PA, Storb R. Mixed chimerism: preclinical studies and clinical applications. Biol Blood Marrow Transplant 1999; 5: 192-203.
30. Vriesendorp HM, van Bekkum DW. Role of total body irradiation in conditioning for bone marrow transplantation. Hamatol Bluttransfus 1980; 25: 349-364.
31. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994; 83: 939-948.
32. Barquinero J et al. Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs. Blood 1995; 85: 1195-1201.
33. Mardiney III M, Malech HL. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy. Blood 1996; 87: 4049-4056.
34. Berger C et al. Nonmyeloablative immunosuppressive regimen prolongs in vivo persistence of gene-modified autologous T cells in a nonhuman primate model. J Virol 2001; 75: 799-808.
35. Stewart FM et al. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood 1998; 91: 3681-3687.
36. Stripecke R et al. Immune response to green fluorescent protein: implications for gene therapy. Gene Therapy 1999; 6: 1305-1312.
37. Izembart A et al. In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response. Hum Gene Ther 1999; 10: 2917-2925.
38. Schiffmann R et al. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene. Blood 1995; 86: 1218-1227.
39. Kang E et al. In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting. Hum Gene Ther 2001; 12: 1663-1672.
40. Carter RF et al. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 1992; 79: 356-364.
41. Rosenzweig M et al. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood 1999; 94: 2271-2286.
42. Lutzko C et al. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood 1999; 93: 1895-1905.
43. Rosenzweig M et al. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood 2001; 97: 1951-1959.
44. Varas F, Bernard A, Bueren JA. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors. Exp Hematol 1998; 26: 100-109.
45. Qin S et al. Competitive repopulation of retrovirally transduced haemopoietic stem cells. Br J Haematol 1999; 107: 162-168.
46. Ramshaw HS et al. Engraftment of bone marrow cells into normal unprepared hosts: effects of 5-fluorouracil and cell cycle status. Blood 1995; 86: 924-929.
47. D'Hondt L et al. Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts. Int J Hematol 2001; 74: 79-85.
48. Limon A et al. High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 1997; 90: 3316-3321.
49. Baum C et al. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69: 7541-7547.
50. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 1991; 19: 206-212.
51. Lee JC, Hapel AJ, Ihle JN. Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. J Immunol 1982; 128: 2393-2398.